533 related articles for article (PubMed ID: 11773421)
1. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.
Beyer WR; Westphal M; Ostertag W; von Laer D
J Virol; 2002 Feb; 76(3):1488-95. PubMed ID: 11773421
[TBL] [Abstract][Full Text] [Related]
2. Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins.
Miletic H; Fischer YH; Neumann H; Hans V; Stenzel W; Giroglou T; Hermann M; Deckert M; Von Laer D
Hum Gene Ther; 2004 Nov; 15(11):1091-100. PubMed ID: 15610609
[TBL] [Abstract][Full Text] [Related]
3. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.
Watson DJ; Kobinger GP; Passini MA; Wilson JM; Wolfe JH
Mol Ther; 2002 May; 5(5 Pt 1):528-37. PubMed ID: 11991743
[TBL] [Abstract][Full Text] [Related]
4. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus.
Miletic H; Bruns M; Tsiakas K; Vogt B; Rezai R; Baum C; Kühlke K; Cosset FL; Ostertag W; Lother H; von Laer D
J Virol; 1999 Jul; 73(7):6114-6. PubMed ID: 10364368
[TBL] [Abstract][Full Text] [Related]
5. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.
Sandrin V; Boson B; Salmon P; Gay W; Nègre D; Le Grand R; Trono D; Cosset FL
Blood; 2002 Aug; 100(3):823-32. PubMed ID: 12130492
[TBL] [Abstract][Full Text] [Related]
7. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
Zhang XY; La Russa VF; Reiser J
J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277
[TBL] [Abstract][Full Text] [Related]
8. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
9. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P.
Beyer WR; Pöpplau D; Garten W; von Laer D; Lenz O
J Virol; 2003 Mar; 77(5):2866-72. PubMed ID: 12584310
[TBL] [Abstract][Full Text] [Related]
10. Generation of high-titer pseudotyped retroviral vectors with very broad host range.
Yee JK; Friedmann T; Burns JC
Methods Cell Biol; 1994; 43 Pt A():99-112. PubMed ID: 7823872
[TBL] [Abstract][Full Text] [Related]
11. Optimized large-scale production of high titer lentivirus vector pseudotypes.
Sena-Esteves M; Tebbets JC; Steffens S; Crombleholme T; Flake AW
J Virol Methods; 2004 Dec; 122(2):131-9. PubMed ID: 15542136
[TBL] [Abstract][Full Text] [Related]
12. Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum.
Pipperger L; Koske I; Wild N; Müllauer B; Krenn D; Stoiber H; Wollmann G; Kimpel J; von Laer D; Bánki Z
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243134
[TBL] [Abstract][Full Text] [Related]
13. Transduction of human islets with pseudotyped lentiviral vectors.
Kobinger GP; Deng S; Louboutin JP; Vatamaniuk M; Matschinsky F; Markmann JF; Raper SE; Wilson JM
Hum Gene Ther; 2004 Feb; 15(2):211-9. PubMed ID: 14975193
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer in human skin with different pseudotyped HIV-based vectors.
Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
[TBL] [Abstract][Full Text] [Related]
15. Altering the tropism of lentiviral vectors through pseudotyping.
Cronin J; Zhang XY; Reiser J
Curr Gene Ther; 2005 Aug; 5(4):387-98. PubMed ID: 16101513
[TBL] [Abstract][Full Text] [Related]
16. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions.
Kahl CA; Pollok K; Haneline LS; Cornetta K
Mol Ther; 2005 Mar; 11(3):470-82. PubMed ID: 15727944
[TBL] [Abstract][Full Text] [Related]
18. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
19. Stability of Retroviral Vectors Against Ultracentrifugation Is Determined by the Viral Internal Core and Envelope Proteins Used for Pseudotyping.
Kim SH; Lim KI
Mol Cells; 2017 May; 40(5):339-345. PubMed ID: 28535668
[TBL] [Abstract][Full Text] [Related]
20. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines.
Arai T; Matsumoto K; Saitoh K; Ui M; Ito T; Murakami M; Kanegae Y; Saito I; Cosset FL; Takeuchi Y; Iba H
J Virol; 1998 Feb; 72(2):1115-21. PubMed ID: 9445007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
